Monday, September 13, 2021

MINDCURE Broadcasts Platinum Sponsorship of the 2021 SANA Symposium

Because the official assembly of the Psychedelic Medication Affiliation, this convention will join psychological well being professionals with promising analysis…

By Staff , in Platinum , at September 9, 2021

Because the official assembly of the Psychedelic Medication Affiliation, this convention will join psychological well being professionals with promising analysis and breakthrough therapy therapies from the rising discipline.

VANCOUVER, BC, Sept. 9, 2021 /PRNewswire/ – Thoughts Remedy Well being Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE” or the “Firm”), a pacesetter in superior proprietary know-how and analysis in psychedelics, is happy to announce its presence on the 2021 SANA Symposium (“SANA”) as a Platinum Sponsor and host of the Innovation Theater.

MINDCURE will likely be participating with clinicians world wide who’ve an curiosity in studying extra about psychedelic-assisted psychotherapy, and particularly in adopting novel protocols and follow requirements round psychedelics. The timing of this convention coincides with the latest launch of iSTRYM, the Firm’s digital therapeutics (DTx) platform for psychedelics, into associate clinics throughout North America.

“We couldn’t ask for a greater time or a greater discussion board to share our firm’s mission, and particularly our developments round iSTRYM, with an engaged and educated viewers with a specific curiosity in psychedelics and psychedelic-assisted psychotherapy,” stated Kelsey Ramsden, President & CEO, MINDCURE.

Becoming a member of Kelsey Ramsden on the SANA Symposium’s Innovation Theater from MINDCURE this yr will likely be Chief Medical Officer Dr. Joel Raskin, Senior Translational and Psychometric Architect Dr. Ty Tashiro, and Advisors Dr. John Brownstein and Dr. Ken Weingardt.

With psychedelics now making waves in mainstream drugs, the SANA Symposium will unite globally-renowned specialists throughout three key follow fields – psychiatry, psychotherapy, and dependancy therapy– to supply a multi-perspective view on the applying and approaches of psychedelic therapies. The Symposium will spotlight promising ends in utilizing psychedelic-assisted remedy to deal with psychological well being problems together with main melancholy, nervousness, and PTSD and can function groundbreaking analysis and cutting-edge information in psychedelics.

SANA is attended by roughly 2000 psychiatrists, psychotherapists, and dependancy specialists and is accredited for varied forms of well being and allied healthcare professionals. This yr’s Symposium will likely be carried out just about on September 17-19, 2021. For extra on the 2021 SANA Symposium, please go to

About Thoughts Remedy Well being Inc.
MINDCURE is a life sciences firm centered on innovating and commercializing new methods to advertise therapeutic and enhance psychological well being. The corporate is growing digital therapeutics know-how and researching psychedelic compounds to assist entry to secure, evidence-based psychedelic-assisted therapies globally. Study extra at, and comply with us on LinkedIn, Fb, Twitter, and Instagram.

On Behalf of the Board of Administrators
Kelsey Ramsden, President & CEO
Cellphone: 1-888-593-8995

Ahead-Trying Data

Ahead-looking info is predicated on numerous key expectations and assumptions made by administration of MINDCURE, together with, with out limitation: the COVID-19 pandemic affect on the Canadian economic system and MINDCURE’s enterprise, and the extent and period of such affect; no change to legal guidelines or laws that negatively have an effect on MINDCURE’s enterprise; there will likely be a requirement for MINDCURE’s merchandise sooner or later; no unanticipated bills or prices come up; MINDCURE will have the ability to proceed to establish merchandise that make them ideally suited candidates for offering options for treating psychological well being; that iSTRYM will likely be developed, optimized and function as contemplated throughout the psychedelics trade; that the Firm will likely be efficient in acquiring the patents utilized for synthesizing ibogaine, or synthesizing ibogaine, or growing synthesized ibogaine for analysis, medical or industrial use; that MINDCURE will advance wellness worldwide; that iSTRYM will likely be delivered to industrial deployment within the close to time period or in any other case or that it’ll cut back signs, enhance high quality of life, or assist transformation and therapeutic, or that the deployment might not happen on the scale or inside the time-frame contemplated.

Though MINDCURE has tried to establish vital components that would trigger precise outcomes, efficiency or achievements to vary materially from these described in forward-looking info introduced, there could also be different components that trigger outcomes, efficiency or achievements to vary from these anticipated, estimated or meant. Accordingly, readers shouldn’t place undue reliance on any forward-looking statements as no forward-looking info might be assured.

Besides as required by relevant securities legal guidelines, forward-looking statements converse solely as of the date on which they’re made and MINDCURE doesn’t undertake any obligation to publicly replace or revise any forward-looking info, whether or not because of new info, future occasions, or in any other case.



View unique content material to obtain multimedia:

SOURCE Thoughts Remedy Well being Inc.

Source link